|
|
Volumn 10, Issue 11, 1999, Pages 1287-1291
|
|
Evolving approaches to cancer drug discovery and development at the National Cancer Institute, USA
|
|
Author keywords
Drug discovery; Early clinical trials
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BUDGET;
CANCER CENTER;
CANCER CHEMOTHERAPY;
CLINICAL RESEARCH;
CLINICAL TRIAL;
DRUG RESEARCH;
GOVERNMENT;
HUMAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
UNITED STATES;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
CLINICAL TRIALS, PHASE III;
DRUG APPROVAL;
DRUGS, INVESTIGATIONAL;
HUMANS;
NATIONAL INSTITUTES OF HEALTH (U.S.);
UNITED STATES;
|
|
EID: 0032764062
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1008333901925 Document Type: Review |
|
Times cited : (34)
|
|
References (6)
|
